In early March, 1.7 million doses of AstraZeneca vaccine, dispatched via the Covax mechanism for poorer countries, arrived in the DRC to a triumphant welcome.
But just afterwards, several European countries suspended vaccination campaigns with AstraZeneca over fears that it caused rare but serious blood clotting.
The DRC authorities postponed the start of vaccinations with AstraZeneca -- the only jab then available in the country -- until mid-April.
